Cargando…

The clinical management of hepatocellular carcinoma in China: Progress and challenges

Detalles Bibliográficos
Autores principales:	Shan, Shan, Jia, Jidong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Association for the Study of the Liver 2023
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10121312/ https://www.ncbi.nlm.nih.gov/pubmed/36924120 http://dx.doi.org/10.3350/cmh.2023.0077

Ejemplares similares

Virus-Induced Risk of Hepatocellular Carcinoma: Recent Progress and Future Challenges
por: Lupberger, Joachim, et al.
Publicado: (2021)

Challenges in translating clinical guidelines into real-life practice for management of hepatocellular carcinoma in Taiwan
por: Chen, San-Chi
Publicado: (2023)

Management of hepatocellular carcinoma in China: Seeking common grounds while reserving differences
por: Yang, Tian, et al.
Publicado: (2023)

Challenges and Future Trends of Hepatocellular Carcinoma Immunotherapy
por: Rizzo, Alessandro, et al.
Publicado: (2022)

Advances in the diagnosis and treatment of viral hepatitis B and C in China
por: Jia, Jidong
Publicado: (2022)

Hepatocellular Carcinoma: Carcinogenesis, Establishment, Progression, and Therapies
por: Guan, Yong-Song, et al.
Publicado: (2014)

Hepatocellular carcinoma in Latin America: Diagnosis and treatment challenges
por: Piñero, Federico, et al.
Publicado: (2018)

Resection vs. transplantation for hepatocellular carcinoma: a never ending challenge
por: Ferrer-Fàbrega, Joana, et al.
Publicado: (2023)

Addressing the Challenges of Hepatitis C Cure and Persistent Risk of Hepatocellular Carcinoma
por: Baumert, Thomas F., et al.
Publicado: (2019)

Progress in hepatectomy for hepatocellular carcinoma and peri-operation management
por: Chen, Hao, et al.
Publicado: (2020)

The prime time for management of hepatocellular carcinoma in Hong Kong
por: Chan, Landon L., et al.
Publicado: (2023)

Extracellular Vesicles in Hepatocellular Carcinoma: Progress and Challenges in the Translation from the Laboratory to Clinic
por: Yan, Rong, et al.
Publicado: (2023)

Hepatocellular carcinoma: early-stage management challenges
por: Erstad, Derek J, et al.
Publicado: (2017)

Hope and Challenges in the Management of Advanced Renal Cell Carcinoma
por: Clark, Peter E.
Publicado: (2007)

Clinical Challenges in the Management of Neuroendocrine Tumors
por: Panzuto, Francesco
Publicado: (2021)

Albumin-bilirubin score: an additional tool for the management of patients with hepatocellular carcinoma
por: Serenari, Matteo, et al.
Publicado: (2020)

Long-term prognosis and management of hepatocellular carcinoma after curative treatment
por: Nishida, Naoshi
Publicado: (2020)

Role of inflammatory indices in management of hepatocellular carcinoma—neutrophil to lymphocyte ratio
por: Shelat, Vishal G.
Publicado: (2020)

Immune Checkpoint Inhibitors in Hepatocellular Carcinoma: Current Progresses and Challenges
por: Liu, Hao-Tian, et al.
Publicado: (2021)

Hepatocellular carcinoma: HCC
por: Blum, Hubert E.
Publicado: (2011)

SPATS2 is correlated with cell cycle progression and immune cells infiltration in hepatocellular carcinoma
por: Lin, Jing, et al.
Publicado: (2023)

P53 expression in hepatocellular carcinoma: influence on the radiotherapeutic response of the hepatocellular carcinoma
por: Lee, Yu Rim, et al.
Publicado: (2015)

Advances and challenges in laparoscopic surgery in the management of hepatocellular carcinoma
por: Ziogas, Ioannis A, et al.
Publicado: (2017)

Recent progress in molecular mechanisms of postoperative recurrence and metastasis of hepatocellular carcinoma
por: Niu, Zhao-Shan, et al.
Publicado: (2022)

Adding to the evidence base: Effectiveness of hepatocellular carcinoma surveillance in clinical practice
por: Pandya, Prashant, et al.
Publicado: (2017)

Interpretation of the 7th edition of the “diagnosis and treatment guidelines of coronavirus disease 2019 in China”: Progress and challenges
por: Xie, Li-Xin
Publicado: (2020)

Cezanne predicts progression and adjuvant TACE response in hepatocellular carcinoma
por: Wang, Jia-hong, et al.
Publicado: (2017)

Progress, challenges, and responsibilities in retrovirology
por: Jeang, Kuan-Teh
Publicado: (2005)

Malaria in 2022: Challenges and Progress
por: Rosenthal, Philip J.
Publicado: (2022)

Welcome to Journal of Hepatocellular Carcinoma
por: Kaseb, Ahmed O
Publicado: (2015)

Molecular heterogeneity in hepatocellular carcinoma
por: Zhu, Shijia, et al.
Publicado: (2018)

Novel Therapies for Hepatocellular Carcinoma
por: Rimassa, Lorenza
Publicado: (2020)

Human Hepatocellular Carcinoma (HCC)
por: Buonaguro, Luigi
Publicado: (2020)

Hot topics in hepatocellular carcinoma
por: Ielasi, Luca, et al.
Publicado: (2019)

Meeting the Challenge of Diabetes in China
por: Luo, Zhen, et al.
Publicado: (2019)

Immunotherapy for the treatment of hepatocellular carcinoma: finally in clinical practice
por: Celsa, Ciro, et al.
Publicado: (2023)

Toward a New Era in the Management of Hepatocellular Carcinoma: Novel Perspectives on Therapeutic Options and Biomarkers
por: Gabbia, Daniela, et al.
Publicado: (2023)

Brucellosis in China: history, progress and challenge
por: Jiang, Hai, et al.
Publicado: (2020)

Current Clinical Management Status of Pulmonary Embolism in China
por: Gong, Juan-Ni, et al.
Publicado: (2017)

Hepatitis elimination by 2030: Progress and challenges
por: Waheed, Yasir, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_lfhtv9piqdsq94l7jmej9c50cm